Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies.
Saved in:
| Title: | Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies. |
|---|---|
| Authors: | Umyarova E; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Sharp J; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Pei C; Department of Medicine, The Ohio State University, Columbus, OH, USA., Pellegrino W; Department of Medicine, The Ohio State University, Columbus, OH, USA., Zhao Q; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Denlinger N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Voorhees T; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., De Lima M; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Epperla N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. naren.epperla@hci.utah.edu.; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. naren.epperla@hci.utah.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Mar 12; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 12. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
